DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia (Q34061159)

30 July 2017

DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia (English)

1 reference

30 July 2017

0 references

1 reference

6

1 reference

30 July 2017

Todd Lencz

1

0 references

author name string

Delbert G Robinson

2

1 reference

30 July 2017

Barbara Napolitano

3

1 reference

30 July 2017

Serge Sevy

4

1 reference

30 July 2017

John M Kane

5

1 reference

30 July 2017

Anil K Malhotra

7

1 reference

30 July 2017

1 September 2010

1 reference

Pharmacogenetics and Genomics

30 July 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 July 2017

20

1 reference

30 July 2017

9

1 reference

30 July 2017

569-572

1 reference

D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

Pharmacogenetics of antipsychotic-induced side effects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

Risperidone alters food intake, core body temperature, and locomotor activity in mice

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo muPET imaging ([11C] raclopride) and in-vitro ([3H] spiperone) autoradiography.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

Half a century of antipsychotics and still a central role for dopamine D2 receptors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

Antipsychotic-induced weight gain: a comprehensive research synthesis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

Dopamine receptor subtype agonists and feeding behavior

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920359

Consensus development conference on antipsychotic drugs and obesity and diabetes

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20664489

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20664489

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/FPC.0B013E32833CA24B

1 reference

30 July 2017

1 reference

30 July 2017

1 reference